Hannah Bruehl
Projektgruppe Nutzenbewertung von Gesundheitstechnologien, German Ministry of Health
Adrian GRIFFIN
VP HTA and Market Access Policy, Johnson & Johnson
Mirella MARLOW
Programme Director – Centre for Health Technology Evaluation, National Institute for Health and Care Excellence (NICE)
Elodie BRIENT-LITZLER
Head of Innovation Development, Technologies for life sciences and MedTech, Institut Pasteur
José DA COSTA
Commercial Director, Institut Carnot INTERFACES
An NGUYEN-DINH
CEO, Cairdac
Nicolas MIGNAN
CEO, Virtuali Surg
Antoine DENIS
Director of development and innovation in healthcare, Microsoft
Jesus RUEDA RODRIGUEZ
Director International Affairs, MedTech Europe
Christian CLARUS
Director Government Affairs, B.Braun Melsungen AG
Mark LLOYD DAVIES
Senior Director, Government Affairs & Policy, Medical Devices EMEA, Johnson & Johnson Western Markets Lead, Johnson & Johnson
João PEREIRA DA COSTA
Legal & Compliance Counsel III, Legal EMEA, Medtronic Portugal
Carmen LAPLAZA SANTOS
Deputy Head of Innovative and Personalised Medicine Unit, European Commission
Götz GERECKE
Senior Partner and Managing Director, Boston Consulting Group (BCG)
Alain MERLE
Strategic Marketing Manager Security, CEA Leti
Martina BARTELINK
Former Senior Policy Advisor, Ministry of Health, Welfare and Sport, Netherlands